To compare dose to organs at risk (OARs) and dose-escalation possibility for 24 stage I non-small cell lung cancer (NSCLC) patients in a ROCOCO (Radiation Oncology Collaborative Comparison) trial.
from Imaging via alkiviadis.1961 on Inoreader http://ift.tt/2DmTDhX
Δευτέρα 12 Μαρτίου 2018
Photons, protons or carbon ions for stage I non-small cell lung cancer – Results of the multicentric ROCOCO in silico study
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Business Cover Letter Writing. The business professional can include a fairly broad group, so make sure you that cold cover letters have a j...
-
Abstract Background Liver resection of benign, primary, and metastatic tumors is challenging and places patients at risk of postoperativ...
-
Writers use the descriptive essay to create a vivid picture of a person, place, or thing. Unlike a narrative essay, which reveals meaning th...
-
Radiomics in Head and Neck Cancer: Extracting Valuable Information from Data beyond Recognition. ORL J Otorhinolaryngol Relat Spec. 20...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nelNZ8 via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου